REYON Pharmaceutical Co., Ltd. (102460.KS)
KRW 13020.0
(-2.18%)
KRW 13020.0
(-2.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 7.13 Billion | 8.72 Billion | 11.68 Billion | 4.59 Billion | -12.18 Billion | 11.44 Billion |
| Net Income | 3.58 Billion | 7.43 Billion | 5.53 Billion | 3.84 Billion | 5.93 Billion | 1.34 Billion |
| Depreciation & Amortization | 4.78 Billion | 4.53 Billion | 4.66 Billion | 4.56 Billion | 4.08 Billion | 1.86 Billion |
| Deferred income taxes | - | - | - | - | - | -28.66 Billion |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.36 Billion | -290.35 Million | 1.78 Billion | -1.27 Billion | 2.62 Billion | 7.58 Billion |
| Other non-cash items | 2.13 Billion | -2.94 Billion | -300.31 Million | -2.53 Billion | -24.83 Billion | 656.45 Million |
| Investing Cash Flow | -8.73 Billion | -52.56 Billion | -114.68 Billion | -29.59 Billion | 32.89 Billion | 7.65 Billion |
| Investments in PPE | -28.87 Billion | -63.13 Billion | -116.99 Billion | -52.31 Billion | -51.38 Billion | -39.41 Billion |
| Acquisitions | 1.72 Million | 42.27 Million | -10.7 Million | 425.83 Million | -4.8 Billion | -2.59 Billion |
| Investment purchases | -10.03 Billion | -65.86 Billion | -85.32 Billion | -2.24 Billion | -420.06 Million | -78.71 Billion |
| Sales/Maturities of investments | 30.01 Billion | 76.42 Billion | 87.4 Billion | 24.46 Billion | 89.4 Billion | 128.65 Billion |
| Other Investing Activities | 152.11 Million | -38.92 Million | 249.8 Million | 70.39 Million | 101.98 Million | -289.23 Million |
| Financing Cash Flow | 8.15 Billion | -6.76 Billion | 157.57 Billion | 31.39 Billion | -23.66 Billion | -10.84 Billion |
| Debt repayment | -13.1 Billion | -113.9 Billion | -151.12 Billion | -30.22 Billion | -26.04 Billion | - |
| Dividends payments | -2.73 Billion | -4.56 Billion | -3.46 Billion | -5.78 Billion | -8.26 Billion | -5.86 Billion |
| Common Stock Repurchased | - | - | -76.3 Million | - | - | -4.97 Billion |
| Common Stock Issuance | -3.83 Million | - | 10 Billion | -45.27 Million | - | - |
| Other Financing Activities | -3.83 Million | 111.69 Billion | 302.24 Billion | 6.95 Billion | 10.64 Billion | - |
| Accounts receivables | 1.89 Billion | -924.92 Million | 200.68 Million | 4.27 Billion | 5.23 Billion | 4.93 Billion |
| Accounts payables | 3.39 Billion | 61.52 Million | 563.6 Million | 49.38 Million | 433.69 Million | 217.83 Million |
| Inventory | -5.06 Billion | -3.67 Billion | 2 Billion | -4.43 Billion | -3.2 Billion | 890.61 Million |
| Other working capital | -3.58 Billion | 4.25 Billion | -987.89 Million | -1.16 Billion | 163.71 Million | 6.69 Billion |
| Cash at beginning of period | 16.04 Billion | 66.74 Billion | 12.19 Billion | 5.82 Billion | 8.77 Billion | 529.96 Million |
| Cash at end of period | 24.1 Billion | 16.04 Billion | 66.74 Billion | 12.19 Billion | 5.82 Billion | 8.77 Billion |
| Capital Expenditure | -28.87 Billion | -63.13 Billion | -116.99 Billion | -52.31 Billion | -51.38 Billion | -39.41 Billion |
| Effect of forex changes on cash | -1.28 Million | -89.03 Million | -33.99 Million | -26.17 Million | -384.75 Thousand | -6.39 Million |
| Net cash flow / Change in cash | 8.05 Billion | -50.69 Billion | 54.54 Billion | 6.37 Billion | -2.95 Billion | 8.24 Billion |
| Free Cash Flow | -21.73 Billion | -54.4 Billion | -105.31 Billion | -47.71 Billion | -63.56 Billion | -27.96 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 659.64 Million | 326.16 Million | 3.58 Billion | -989.35 Million | -100.92 Million | 2.66 Billion |
| Depreciation & Amortization | 997.13 Million | 1.06 Billion | 4.78 Billion | 1.07 Billion | 1.21 Billion | 1.27 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.9 Billion | -3.43 Billion | -3.36 Billion | -3.35 Billion | -330.61 Million | 1.23 Billion |
| Other non-cash items | -318.61 Million | 5.49 Billion | 2.13 Billion | 2.89 Billion | -104.6 Million | -347.46 Million |
| Investing Cash Flow | -7.36 Billion | -5.34 Billion | -8.73 Billion | -5.39 Billion | 935.16 Million | -4.85 Billion |
| Investments in PPE | -6.36 Billion | -5.35 Billion | -28.87 Billion | -5.54 Billion | -7.59 Billion | -6.36 Billion |
| Acquisitions | 4.26 Million | -4.26 Million | 1.72 Million | - | 80 Thousand | 140.8 Thousand |
| Investment purchases | -999.99 Million | - | -10.03 Billion | - | -80 Thousand | -140.8 Thousand |
| Sales/Maturities of investments | 9.88 Million | - | 30.01 Billion | -10.00 | 8 Billion | 2.01 Billion |
| Other Investing Activities | -996.91 Million | 16 Million | 152.11 Million | 151.64 Million | 533.03 Million | -504.77 Million |
| Financing Cash Flow | -5.15 Billion | -407.89 Million | 8.15 Billion | -409.03 Million | -566.11 Million | 9.7 Billion |
| Debt repayment | -2.4 Billion | -407.89 Million | -13.1 Billion | -409.03 Million | -562.28 Million | -13.1 Billion |
| Dividends payments | -2.75 Billion | - | -2.73 Billion | - | - | -2.73 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -3.83 Million | - | -3.83 Million | - |
| Other Financing Activities | -404.44 Million | - | -3.83 Million | -10.00 | -562.28 Million | 25.54 Billion |
| Accounts receivables | 990.92 Million | 1.13 Billion | 1.89 Billion | -1.02 Billion | -1.3 Billion | 440.97 Million |
| Accounts payables | 615.34 Million | -2.14 Billion | 3.39 Billion | 1.34 Billion | 762.67 Million | 2.71 Billion |
| Inventory | 503.56 Million | -1.64 Billion | -5.06 Billion | -3.52 Billion | 318.14 Million | -3.56 Billion |
| Other working capital | 409.82 Million | -781.38 Million | -3.58 Billion | -147.21 Million | -106.17 Million | 1.65 Billion |
| Cash at beginning of period | 17.22 Billion | 24.1 Billion | 16.04 Billion | 30.06 Billion | 29 Billion | 19.38 Billion |
| Cash at end of period | 7.88 Billion | 17.22 Billion | 24.1 Billion | 24.1 Billion | 30.06 Billion | 29 Billion |
| Capital Expenditure | -6.36 Billion | -5.35 Billion | -28.87 Billion | -5.54 Billion | -7.59 Billion | -6.36 Billion |
| Effect of forex changes on cash | -61.44 Million | -4.6 Million | -1.28 Million | -11.03 Million | 7.89 Million | -72.98 Million |
| Net cash flow / Change in cash | -9.34 Billion | -6.88 Billion | 8.05 Billion | -5.95 Billion | 1.05 Billion | 9.62 Billion |
| Free Cash Flow | -3.12 Billion | -6.68 Billion | -21.73 Billion | -5.91 Billion | -6.91 Billion | -1.52 Billion |
001020
ZEVY
OPTIEMUS
600111
RPPINFRA
VIBEF